September 12, 2023 — The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is ...
May 18, 2021 — The experimental heart failure drug omecamtiv mecarbil reduced heart failure hospitalizations by a ...
October 31, 2018 — Amgen announced a new Repatha cardiovascular outcomes study (FOURIER) analysis evaluating the effects ...
April 3, 2017 — There is no evidence that adding a new cholesterol-lowering drug to treatment with a statin causes ...
March 20, 2017 — The most important late-breaking pharmaceutical trial at the 2017 America College of Cardiology annual ...
April 16, 2015 — The U.S. Food and Drug Administration (FDA) approved Amgen’s ivabradine (Corlanor) to reduce ...